ABSTRACT Introduction SARS-CoV-2, the causative agent of COVID-19, attacks the
immune system causing an exaggerated and uncontrolled release of pro-inflammatory …

Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) commonly complicates
with coagulopathy. A syndrome called Long-COVID-19 is emerging recently in COVID-19 …

Latest evidences from literature suggest that SARS-CoV-2 disease 2019 (COVID-19) is
commonly complicated with coagulopathy and that disseminated intravascular coagulation …

December 2019 will never be forgotten in the history of medicine when an outbreak of
pneumonia of unknown etiology in Wuhan, China sooner or later prompted the World Health …

Thrombotic complications of the novel coronavirus (COVID-19) are a concerning aspect of
the disease, due to the high incidence in critically ill patients and poor clinical outcomes …

Abstract COVID-19-associated coagulopathy (CAC) is a feature of COVID-19 that can lead
to various thrombotic complications and death. In this review, we briefly highlight possible …

Coronavirus-2019 (COVID-19) predisposes patients to arterial and venous thrombosis
commonly complicating the clinical course of hospitalized patients and attributed to the …

Since the first description of COVID-19 infection, among clinical manifestations of the
disease, including fever, dyspnea, cough, and fatigue, it was observed a high incidence of …

In critically ill patients with acute respiratory distress syndrome (ARDS) coronavirus disease
2019 (COVID-19), a high incidence of thromboembolic and hemorrhagic events is reported …

The cardinal pathology of coronavirus disease 2019 (COVID-19) is a primary infection of
pulmonary tract cells by severe acute respiratory syndrome coronavirus 2, provoking a local …